Pfizer has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 3, 2021, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021. Pursuant to the Pfizer - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company was closed from Thursday, September 30, 2021 (close of business) till 48 hours after the results are made public on November 3, 2021.
The above information is a part of company’s filings submitted to BSE.
